Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Mol Biol Rep ; 51(1): 173, 2024 Jan 22.
Article in English | MEDLINE | ID: mdl-38252175

ABSTRACT

BACKGROUND: DNA methylation, one of the most stable forms of epigenetic modification is associated with the development and progression of coronary artery disease (CAD). Our previously reported study on epigenome-wide microarray analysis showed significantly methylated CpG sites. Top 5 significant CpGs from HLA gene were selected and analysed by Pyrosequencing (PSQ) to determine their association with severity of CAD. METHODS: Blood samples of 50-age matched angiographically CAD positive male cases with 50 angiographically CAD negative male controls were subjected to lipid profile estimation and PSQ for methylation level analysis. Findings and subgroup analysis were evaluated by Mann-Whitney U; Kruskal-Wallis' rank test and two-way ANOVA by MedCalc (v19.6). RESULTS: Methylation levels in HLA-DQA1 for cg10217052 was 78.5 (37-85) and 76.5 (24-84); cg09411910 was 81 (72.0 to 93.0) and 81.5 (50.0 to 89.0) in cases and controls respectively. Levels in HLA-DQB1-cg03344051, were 28.88 + 9.41 for cases and 30.36 + 9.37 in controls. For HLA-DRB1-cg07889003, levels in cases and controls were 15.5 (5.00-39.00) and 10.5 (5.00-29.0); while in cg08269402 were 52 (16-65) and 42.5 (17-61) respectively. No association was observed between methylation levels and lipid profile. cg03344051, cg07889003 and cg08269402 were significantly differentiated in double or triple vessel disease (DVD or TVD) as compared to single vessel disease (SVD) suggesting an increase in the extent of methylation with the increase in CAD severity. CONCLUSION: The present study shows significant increase in the extent of methylation in 3 CpG sites in DVD/TVD cases as compared to SVD cases. Additionally, a novel site, cg07889003 identified in our discovery phase has shown association with the severity of CAD.


Subject(s)
Coronary Artery Disease , Vascular Diseases , Humans , Male , Coronary Artery Disease/genetics , DNA Methylation/genetics , Epigenesis, Genetic/genetics , Lipids
2.
J Hum Genet ; 66(10): 983-993, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33864011

ABSTRACT

Familial Hypercholesterolemia (FH) is an autosomal, dominant, inherited disorder characterized by severely elevated LDL-cholesterol (LDL-C) levels with high risk for Coronary Artery Disease (CAD). There are limited genetic studies especially on genes other than Low Density Lipoprotein receptor (LDLR) conducted in Indian population. Thus, our aim was to screen the entire Proprotein Convertase Subtilisin/Kexin type 9 gene (PCSK9) gene & hotspot exons 3, 4 and 9 of LDLR gene in FH cases and controls. 50 FH cases were categorized into definite, probable and possible cases according to Dutch Lipid Network Criteria (DLNC) who were gender matched with 50 healthy controls. All 12 exons of PCSK9, and hotspot exons 3, 4 & 9 of LDLR gene were screened through High Resolution Melt (HRM) curve analysis. Enzyme linked immunosorbent assay was performed to measure circulating PCSK9 levels. Total cholesterol and LDL-C were significantly high in all three groups of cases. Total 8 nonpathogenic variants in exon 1, 5, 7 and 9 of the PCSK9 gene were detected. In LDLR gene, 3 known pathogenic and 1 benign variant were found in exon 3 & 4. In FH cases, PCSK9 levels were significantly high compared to controls (P = 0.0001), and were directly correlated to LDL-C (P = 0.0001) and Total Cholesterol (P = 0.0001). Our study is first to screen the entire PCSK9 gene in western part of India. Since no pathogenic variants were identified, it is possible that PCSK9 variants are clinically less relevant. However, 3 known pathogenic variants were found in the LDLR gene. These findings support our understanding of the genetic spectrum of FH in India.


Subject(s)
Genetic Predisposition to Disease , Hyperlipoproteinemia Type II/genetics , Proprotein Convertase 9/genetics , Receptors, LDL/genetics , Adult , Asian People/genetics , Cholesterol, LDL , Exons/genetics , Female , Genetic Variation/genetics , Humans , Hyperlipoproteinemia Type II/epidemiology , Hyperlipoproteinemia Type II/pathology , India/epidemiology , Male , Middle Aged , Mutation/genetics , Phenotype
3.
Indian Heart J ; 58(2): 160-3, 2006.
Article in English | MEDLINE | ID: mdl-18989064

ABSTRACT

Patients with concomitant carotid and left main or left main equivalent coronary artery disease are at high risk of both cardiac and cerebrovascular complications when they undergo revascularization procedures. Here, we present case reports of three patients who successfully underwent elective carotid stenting prior to coronary artery bypass surgery. Any sort of intervention in these patients is fraught with high risk due to the severity of their carotid and coronary artery disease.


Subject(s)
Carotid Stenosis/therapy , Coronary Artery Bypass , Coronary Stenosis/surgery , Stents , Aged , Carotid Stenosis/epidemiology , Comorbidity , Coronary Angiography , Coronary Stenosis/diagnostic imaging , Coronary Stenosis/epidemiology , Humans , Male , Middle Aged , Stroke/prevention & control
4.
Ann Thorac Surg ; 78(3): 1068-70, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15337052

ABSTRACT

Pseudoaneurysm of the right ventricular outflow tract after homograft placement is an infrequent complication after intracardiac repair for tetralogy of Fallot. We report two cases of pseudoaneurysm of right ventricular outflow tract after homograft placement for surgical repair of tetralogy of Fallot with pulmonary atresia.


Subject(s)
Aneurysm, False/etiology , Tetralogy of Fallot/surgery , Transplantation, Homologous/adverse effects , Adolescent , Child , Female , Humans , Male , Pulmonary Atresia/complications , Pulmonary Atresia/surgery , Tetralogy of Fallot/complications
SELECTION OF CITATIONS
SEARCH DETAIL